Filing Details
- Accession Number:
- 0001209191-22-060154
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-07 16:29:11
- Reporting Period:
- 2022-12-05
- Accepted Time:
- 2022-12-07 16:29:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1822711 | Pardes Biosciences Inc. | PRDS | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1208907 | G Thomas Wiggans | C/O Pardes Biosciences, Inc. 2173 Salk Ave., Suite 250, Pmb #052 Carlsbad CA 92008 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-12-05 | 12,500 | $1.09 | 50,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price in Column 4 is a weighted average price. The prices actually paid ranged from $1.02 to $1.20. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.